OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
Feras M. Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 14
Feras M. Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 14
Showing 14 citing articles:
The Relapse of Psoriasis: Mechanisms and Mysteries
Danning Tian, Yuping Lai
JID Innovations (2022) Vol. 2, Iss. 3, pp. 100116-100116
Open Access | Times Cited: 63
Danning Tian, Yuping Lai
JID Innovations (2022) Vol. 2, Iss. 3, pp. 100116-100116
Open Access | Times Cited: 63
Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches
Marija V. Medovic, Vladimir Jakovljević, Vladimir Živković, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 54
Marija V. Medovic, Vladimir Jakovljević, Vladimir Živković, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 54
Inflammation and Psoriasis: A Comprehensive Review
Alessandra-Mădălina Man, Meda Sandra Orăsan, Oana-Alina Hoteiuc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16095-16095
Open Access | Times Cited: 41
Alessandra-Mădălina Man, Meda Sandra Orăsan, Oana-Alina Hoteiuc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16095-16095
Open Access | Times Cited: 41
Restoring the Balance between Pro-Inflammatory and Anti-Inflammatory Cytokines in the Treatment of Rheumatoid Arthritis: New Insights from Animal Models
Adrienn Markovics, Ken S. Rosenthal, Katalin Mikecz, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 44-44
Open Access | Times Cited: 34
Adrienn Markovics, Ken S. Rosenthal, Katalin Mikecz, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 44-44
Open Access | Times Cited: 34
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge
Angelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 12, pp. 1445-1451
Closed Access | Times Cited: 26
Angelo Ruggiero, Elisa Camela, Luca Potestio, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 12, pp. 1445-1451
Closed Access | Times Cited: 26
Emiliano Panieri, Pelin Telkoparan‐Akillilar, Luciano Saso
BioFactors (2022) Vol. 49, Iss. 2, pp. 228-250
Closed Access | Times Cited: 16
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 2
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 2
Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals
Eleftheria Tampouratzi, Markos Papakonstantis, John Katsantonis, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 7
Open Access | Times Cited: 9
Eleftheria Tampouratzi, Markos Papakonstantis, John Katsantonis, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 7
Open Access | Times Cited: 9
Uncovering the Differences: How DLQI and WHO-5 Scores Vary in Moderate-to-Severe Psoriasis Patients Treated with Tildrakizumab 100 mg vs. 200 mg?
Emanuele Trovato, Martina Dragotto, Eugenio Capalbo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5240-5240
Open Access | Times Cited: 1
Emanuele Trovato, Martina Dragotto, Eugenio Capalbo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5240-5240
Open Access | Times Cited: 1
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics
Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology (2022) Vol. 157, Iss. 6
Closed Access | Times Cited: 6
Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, et al.
Italian Journal of Dermatology and Venereology (2022) Vol. 157, Iss. 6
Closed Access | Times Cited: 6
Unveiling Psoriasis: Delving into Pathogenesis, Treatment Breakthroughs, and Patent Trends
Azad Kumar Maurya, Dharmendra Jain
Recent Advances in Inflammation & Allergy Drug Discovery (2024) Vol. 19, Iss. 1, pp. 31-45
Closed Access
Azad Kumar Maurya, Dharmendra Jain
Recent Advances in Inflammation & Allergy Drug Discovery (2024) Vol. 19, Iss. 1, pp. 31-45
Closed Access
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs
Viviana Lora, Dario Graceffa, Monia Di Prete, et al.
Dermatology Reports (2024)
Open Access
Viviana Lora, Dario Graceffa, Monia Di Prete, et al.
Dermatology Reports (2024)
Open Access
Emerging Treatment Regimens in Psoriasis: Are There Advantages Over Current Biologic Therapies?
Joeseph Nenow, Esthe Balogh, Steven R. Feldman
EMJ Dermatology (2021), pp. 106-121
Open Access | Times Cited: 1
Joeseph Nenow, Esthe Balogh, Steven R. Feldman
EMJ Dermatology (2021), pp. 106-121
Open Access | Times Cited: 1
New therapeutic targets for the management of moderate-severe psoriasis
José C. Ruiz-Carrascosa, Ángela Ayén‐Rodríguez, José M. Llamas-Molina, et al.
Journal of IMIDs (2022) Vol. 2, Iss. 2
Open Access
José C. Ruiz-Carrascosa, Ángela Ayén‐Rodríguez, José M. Llamas-Molina, et al.
Journal of IMIDs (2022) Vol. 2, Iss. 2
Open Access
